265 related articles for article (PubMed ID: 24973441)
1. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis.
Maricic I; Halder R; Bischof F; Kumar V
J Immunol; 2014 Aug; 193(3):1035-46. PubMed ID: 24973441
[TBL] [Abstract][Full Text] [Related]
2. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
[TBL] [Abstract][Full Text] [Related]
3. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.
Halder RC; Aguilera C; Maricic I; Kumar V
J Clin Invest; 2007 Aug; 117(8):2302-12. PubMed ID: 17641782
[TBL] [Abstract][Full Text] [Related]
4. Sulfatide-activated type II NKT cells suppress immunogenic maturation of lung dendritic cells in murine models of asthma.
Pan H; Zhang G; Nie H; Li S; He S; Yang J
Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L578-L590. PubMed ID: 31432714
[TBL] [Abstract][Full Text] [Related]
5. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
[TBL] [Abstract][Full Text] [Related]
6. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
7. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
[TBL] [Abstract][Full Text] [Related]
8. B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.
Brandl C; Ortler S; Herrmann T; Cardell S; Lutz MB; Wiendl H
PLoS One; 2010 May; 5(5):e10800. PubMed ID: 20520738
[TBL] [Abstract][Full Text] [Related]
9. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
Maricic I; Sheng H; Marrero I; Seki E; Kisseleva T; Chaturvedi S; Molle N; Mathews SA; Gao B; Kumar V
Hepatology; 2015 Apr; 61(4):1357-69. PubMed ID: 25477000
[TBL] [Abstract][Full Text] [Related]
11. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
12. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
13. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
[TBL] [Abstract][Full Text] [Related]
14. NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice.
Waddell A; Zhao J; Cantorna MT
Int Immunol; 2015 May; 27(5):237-44. PubMed ID: 25574039
[TBL] [Abstract][Full Text] [Related]
15. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
[TBL] [Abstract][Full Text] [Related]
16. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
18. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells.
Jeon SB; Yoon HJ; Park SH; Kim IH; Park EJ
J Immunol; 2008 Dec; 181(11):8077-87. PubMed ID: 19018000
[TBL] [Abstract][Full Text] [Related]
19. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma.
Zhang G; Nie H; Yang J; Ding X; Huang Y; Yu H; Li R; Yuan Z; Hu S
Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L975-84. PubMed ID: 21856813
[TBL] [Abstract][Full Text] [Related]
20. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
